Please login to the form below

Not currently logged in
Email:
Password:

Principles of joint NHS/pharmaceutical industry initiatives

Principles of joint NHS/pharmaceutical industry initiatives
  • All joint working between the pharmaceutical industry and the NHS must be for the benefits of patients
  • The interests of individual patients must be protected
  • Clinical aspects of care, including the development of guidelines and protocols, should be under local/national NHS control, and industry input is legitimate and offers potential benefits to patients and NHS organisations
  • Long-term strategic partnership is the desired outcome, but work should proceed on a project by project basis
  • All patient identifiers should be removed from data to respect and preserve patient confidentiality in line with the Data Protection Act
  • Reports or information pertaining to the project/agreement should not be used or published without explicit permission given by all partners entering the agreement
  • Joint working should not be seen as an endorsement or promotion of a specific medicine or technology
  • Joint working should not undermine or conflict with the ethical requirements of any healthcare professional, including the duty of the clinicians to provide whatever treatment they consider clinically appropriate
  • Pharmaceutical companies must comply with the ABPI Code of Practice for the Pharmaceutical Industry at all times
  • All NHS employed staff must comply with NHS (and relevant professional bodies) codes of conduct at all times
  • Pharmaceutical company size (turnover) should not dictate involvement with the NHS
  • If joint working involves research, then best research practice should be applied and consultation with the relevant Local Research Ethics Committee should be sought.

Source: ABPI: NHS and Pharmaceutical Industry Working Together for Patients, 2005

2nd September 2008

Share

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Branding Science

We are Branding Science Partners in thinking which inspires change in healthcare Branding Science are an award-winning global pharmaceutical market...

Latest intelligence

Biosimilars and beyond: innovating for improved patient outcomes
How Europe’s biosimilar landscape has rapidly evolved over the last two decades, bringing biological medicines to more patients than ever before...
World Cancer Day 2023 – closing the gaps in cancer care to give more patients access to life-changing medicines
Great Expectations – exploring the counterpoint between advances in oncology and the challenges of ensuring life-changing medicines reach patients...
Strategic behaviour
Strong strategising depends on your colleagues’ behaviour...